{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:55:58Z","timestamp":1773687358338,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"MERC PGIMER","award":["IM\/135\/23-09-21-0114"],"award-info":[{"award-number":["IM\/135\/23-09-21-0114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40291-025-00779-5","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:35:08Z","timestamp":1743899708000},"page":"407-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-4154","authenticated-orcid":false,"given":"Sreejesh","family":"Sreedharanunni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venus","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Updesh Singh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanshi","family":"Raina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabhajit","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shano","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pulkit","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arihant","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"779_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","volume":"482","author":"AS Duffield","year":"2023","unstructured":"Duffield AS, Mullighan CG, Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia\/lymphoma. Virchows Arch. 2023;482:11\u201326.","journal-title":"Virchows Arch"},{"key":"779_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101242","volume":"34","author":"I Aldoss","year":"2021","unstructured":"Aldoss I, Advani AS. Have any strategies in Ph-like ALL been shown to be effective? Best Pract Res Clin Haematol. 2021;34: 101242.","journal-title":"Best Pract Res Clin Haematol"},{"key":"779_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70161","volume":"13","author":"X Wu","year":"2024","unstructured":"Wu X, Lu S, Zhang X, Yang Z, Sun A, Wu D, et al. The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia. Cancer Med. 2024;13: e70161.","journal-title":"Cancer Med"},{"key":"779_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","volume":"36","author":"M Stanulla","year":"2018","unstructured":"Stanulla M, Dagdan E, Zaliova M, M\u00f6ricke A, Palmi C, Cazzaniga G, et al. IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36:1240\u20139.","journal-title":"J Clin Oncol"},{"key":"779_CR6","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1200\/JCO.23.02238","volume":"42","author":"TC Chang","year":"2024","unstructured":"Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, et al. Genomic determinants of outcome in acute lymphoblastic leukemia. J Clin Oncol. 2024;42:3491\u2013503.","journal-title":"J Clin Oncol"},{"key":"779_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa2024534","volume":"384","author":"EJ Duncavage","year":"2021","unstructured":"Duncavage EJ, Schroeder MC, O\u2019Laughlin M, Wilson R, MacMillan S, Bohannon A, et al. Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers. N Engl J Med. 2021;384:924\u201335.","journal-title":"N Engl J Med"},{"key":"779_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12288-018-0997-y","volume":"34","author":"S Totadri","year":"2018","unstructured":"Totadri S, Singh M, Trehan A, Varma N, Bhatia P. Keeping PACE with Ph-positive to Ph-like detection in B-lineage acute lymphoblastic leukemia: a practical and cost effective (PACE) approach in a resource-constrained setting. Indian J Hematol Blood Transfus. 2018;34:595\u2013601.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"779_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/10428194.2021.1999439","volume":"63","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Binota J, et al. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2022;63:633\u201343.","journal-title":"Leuk Lymphoma"},{"key":"779_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41416-023-02294-y","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sreedharanunni S, Abdulkadir SA, Naseem S, Sachdeva MUS, et al. Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting. Br J Cancer. 2023;129:143\u201352.","journal-title":"Br J Cancer"},{"key":"779_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncr.35051","volume":"130","author":"DG Gupta","year":"2024","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Sreedharanunni S, Sachdeva MUS, Naseem S, et al. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia. Cancer. 2024;130:713\u201326.","journal-title":"Cancer"},{"key":"779_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.34665","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Sreedharanunni S, et al. Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: a report of Indian patients. Cancer. 2023;129:1217\u201326.","journal-title":"Cancer"},{"key":"779_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41408-020-0313-6","volume":"10","author":"N Patkar","year":"2020","unstructured":"Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, et al. NARASIMHA: Novel assay based on targeted RNA sequencing to identify chimeric gene fusions in hematological malignancies. Blood Cancer J. 2020;10:50.","journal-title":"Blood Cancer J"},{"key":"779_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cyto.a.22803","volume":"89","author":"P Tembhare","year":"2016","unstructured":"Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, et al. A novel and easy FxCycleTM violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping. Cytom A. 2016;89:281\u201391.","journal-title":"Cytom A"},{"key":"779_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/cyto.b.21765","volume":"96","author":"N Gupta","year":"2019","unstructured":"Gupta N, Parihar M, Banerjee S, Brahma S, Pawar R, Rath A, et al. FxCycleTM based ploidy correlates with cytogenetic ploidy in B-cell acute lymphoblastic leukemia and is able to detect the aneuploid minimal residual disease clone. Cytom B Clin Cytom. 2019;96:359\u201367.","journal-title":"Cytom B Clin Cytom"},{"key":"779_CR16","doi-asserted-by":"publisher","unstructured":"Nicorici D, \u015eatalan M, Edgren H, Kangaspeska S, Murum\u00e4gi A, Kallioniemi O, et al. FusionCatcher\u2014a tool for finding somatic fusion genes in paired-end RNA-sequencing data. 2014. https:\/\/doi.org\/10.1101\/011650.","DOI":"10.1101\/011650"},{"key":"779_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T, Burkhardt P, Fr\u00f6hlich M, Hutter B, et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 2021;31:448\u201360.","journal-title":"Genome Res"},{"key":"779_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 2019;20:213.","journal-title":"Genome Biol"},{"key":"779_CR19","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.3390\/cancers15194731","volume":"15","author":"AJ Thomson","year":"2023","unstructured":"Thomson AJ, Rehn JA, Heatley SL, Eadie LN, Page EC, Schutz C, et al. Reproducible bioinformatics analysis workflows for detecting IGH gene fusions in B-cell acute lymphoblastic leukaemia patients. Cancers (Basel). 2023;15:4731.","journal-title":"Cancers (Basel)"},{"key":"779_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/15476286.2021.1940047","volume":"18","author":"S Singh","year":"2021","unstructured":"Singh S, Li H. Comparative study of bioinformatic tools for the identification of chimeric RNAs from RNA Sequencing. RNA Biol. 2021;18:254\u201367.","journal-title":"RNA Biol"},{"key":"779_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100467","volume":"3","author":"BJ Haas","year":"2023","unstructured":"Haas BJ, Dobin A, Ghandi M, Van Arsdale A, Tickle T, Robinson JT, et al. Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector. Cell Rep Methods. 2023;3: 100467.","journal-title":"Cell Rep Methods"},{"key":"779_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1200\/CCI.19.00132","volume":"4","author":"KA Pagel","year":"2020","unstructured":"Pagel KA, Kim R, Moad K, Busby B, Zheng L, Tokheim C, et al. Integrated informatics analysis of cancer-related variants. JCO Clin Cancer Inform. 2020;4:310\u20137.","journal-title":"JCO Clin Cancer Inform"},{"key":"779_CR23","unstructured":"TrinityCTAT\/ctat-mutations [Internet]. 2024. https:\/\/github.com\/TrinityCTAT\/ctat-mutations. Accessed 21 Nov 2024."},{"key":"779_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","volume":"24","author":"P Horak","year":"2022","unstructured":"Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, et al. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med. 2022;24:986\u201398.","journal-title":"Genet Med"},{"key":"779_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.12688\/f1000research.129490.1","volume":"12","author":"A Lonsdale","year":"2023","unstructured":"Lonsdale A, Halman A, Brown L, Kosasih H, Ekert P, Oshlack A. Toblerone: detecting exon deletion events in cancer using RNA-seq. F1000Res. 2023;12:130.","journal-title":"F1000Res"},{"key":"779_CR26","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1097\/MPH.0000000000001892","volume":"43","author":"P Sharma","year":"2020","unstructured":"Sharma P, Rana S, Sreedharanunni S, Gautam A, Sachdeva MUS, Naseem S, et al. An evaluation of a fluorescence in situ hybridization strategy using air-dried blood and bone-marrow smears in the risk stratification of pediatric B-lineage acute lymphoblastic leukemia in resource-limited settings. J Pediatr Hematol Oncol. 2020;43:e481-485.","journal-title":"J Pediatr Hematol Oncol"},{"key":"779_CR27","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/10428194.2021.1929964","volume":"63","author":"P Sharma","year":"2022","unstructured":"Sharma P, Rana S, Virk H, Sachdeva MUS, Sharma P, Varma N, et al. The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India. Leuk Lymphoma. 2022;63:2474\u20138.","journal-title":"Leuk Lymphoma"},{"key":"779_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","volume":"37","author":"SL Ryan","year":"2023","unstructured":"Ryan SL, Peden JF, Kingsbury Z, Schwab CJ, James T, Polonen P, et al. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia. Leukemia. 2023;37:518\u201328.","journal-title":"Leukemia"},{"key":"779_CR29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","volume":"37","author":"C Meyer","year":"2023","unstructured":"Meyer C, Larghero P, Almeida Lopes B, Burmeister T, Gr\u00f6ger D, Sutton R, et al. The KMT2A recombinome of acute leukemias in 2023. Leukemia. 2023;37:988\u20131005.","journal-title":"Leukemia"},{"key":"779_CR30","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.3324\/haematol.2015.136499","volume":"101","author":"N Duployez","year":"2016","unstructured":"Duployez N, Grzych G, Ducourneau B, Alarcon Fuentes M, Grardel N, Boyer T, et al. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. Haematologica. 2016;101:e133-134.","journal-title":"Haematologica"},{"key":"779_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5045\/br.2022.2022134","volume":"57","author":"H Virk","year":"2022","unstructured":"Virk H, Sreedharanunni S, Palla S, Rastogi P, Rathore S, Anshu A, et al. Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia\u2014an illustrative report and review of literature. Blood Res. 2022;57:278\u201381.","journal-title":"Blood Res"},{"key":"779_CR32","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1182\/blood-2012-09-456517","volume":"120","author":"T Eyre","year":"2012","unstructured":"Eyre T, Schwab CJ, Kinstrie R, McGuire AK, Strefford J, Peniket A, et al. Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia. Blood. 2012;120:4441\u20133.","journal-title":"Blood"},{"key":"779_CR33","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1097\/MPH.0000000000001007","volume":"40","author":"SI Tsujimoto","year":"2018","unstructured":"Tsujimoto SI, Nakano Y, Osumi T, Okada K, Ouchi-Uchiyama M, Kataoka K, et al. A Cryptic NUP214-ABL1 fusion in B-cell precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2018;40:e397\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"779_CR34","doi-asserted-by":"publisher","first-page":"2186040","DOI":"10.1080\/16078454.2023.2186040","volume":"28","author":"Z Chen","year":"2023","unstructured":"Chen Z. The e1a3 BCR-ABL1 fusion transcript in Philadelphia chromosome-positive acute lymphoblastic leukaemia: a case report. Hematology. 2023;28:2186040.","journal-title":"Hematology"},{"key":"779_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cancergen.2015.12.014","volume":"209","author":"D Kurita","year":"2016","unstructured":"Kurita D, Hatta Y, Hojo A, Kura Y, Sawada U, Kanda Y, et al. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR\/ABL1 fusion transcript. Cancer Genet. 2016;209:161\u20135.","journal-title":"Cancer Genet"},{"key":"779_CR36","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41375-018-0093-1","volume":"32","author":"X Dong","year":"2018","unstructured":"Dong X, Zhang W, Wu H, Huang J, Zhang M, Wang P, et al. Structural basis of DUX4\/IGH-driven transactivation. Leukemia. 2018;32:1466\u201376.","journal-title":"Leukemia"},{"key":"779_CR37","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.3324\/haematol.2018.214353","volume":"104","author":"D Schinnerl","year":"2019","unstructured":"Schinnerl D, Mejstrikova E, Schumich A, Zaliova M, Fortschegger K, Nebral K, et al. CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia. Haematologica. 2019;104:e352\u20135.","journal-title":"Haematologica"},{"key":"779_CR38","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebj\u00f6rn","year":"2016","unstructured":"Lilljebj\u00f6rn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790.","journal-title":"Nat Commun"},{"key":"779_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41408-024-01099-3","volume":"14","author":"D Schinnerl","year":"2024","unstructured":"Schinnerl D, Riebler M, Schumich A, Haslinger S, Bramb\u00f6ck A, Inthal A, et al. Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia. Blood Cancer J. 2024;14:119.","journal-title":"Blood Cancer J"},{"key":"779_CR40","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3324\/haematol.2021.278697","volume":"106","author":"LM Niswander","year":"2021","unstructured":"Niswander LM, Loftus JP, Lainey \u00c9, Caye-Eude A, Pondrom M, Hottman DA, et al. Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica. 2021;106:2763\u20137.","journal-title":"Haematologica"},{"key":"779_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151514","volume":"46","author":"W Liu","year":"2020","unstructured":"Liu W, Thakral B, Tang G, Wang W, Medeiros LJ, Konoplev S. From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH\/EPOR fusion. Ann Diagn Pathol. 2020;46: 151514.","journal-title":"Ann Diagn Pathol"},{"key":"779_CR42","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.1007\/s00277-024-06114-y","volume":"103","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang Q, Shao H. Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia. Ann Hematol. 2024;103:5599\u2013605.","journal-title":"Ann Hematol"},{"key":"779_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bjc.2017.152","volume":"117","author":"M Forero-Castro","year":"2017","unstructured":"Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hern\u00e1ndez-S\u00e1nchez M, et al. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia. Br J Cancer. 2017;117:256\u201365.","journal-title":"Br J Cancer"},{"key":"779_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.942053","volume":"10","author":"CE Downes","year":"2022","unstructured":"Downes CE, McClure BJ, McDougal DP, Heatley SL, Bruning JB, Thomas D, et al. JAK2 alterations in acute lymphoblastic leukemia: molecular insights for superior precision medicine strategies. Front Cell Dev Biol. 2022;10: 942053.","journal-title":"Front Cell Dev Biol"},{"key":"779_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41417-019-0120-z","volume":"27","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Y, Wang F, Wang M, Liu H, Chen X, et al. The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia. Cancer Gene Ther. 2020;27:81\u20138.","journal-title":"Cancer Gene Ther"},{"key":"779_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019;51:296\u2013307.","journal-title":"Nat Genet"},{"key":"779_CR47","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood.2020010144","volume":"138","author":"E Paietta","year":"2021","unstructured":"Paietta E, Roberts KG, Wang V, Gu Z, Buck GAN, Pei D, et al. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. Blood. 2021;138:948\u201358.","journal-title":"Blood"},{"key":"779_CR48","first-page":"e31443","volume":"35","author":"P Bhatia","year":"2024","unstructured":"Bhatia P, Thakur R, Sreedharanunni S, Singh M, Malhotra M, Arora S, et al. Clinical utility of a novel triplex digital pcr assay for clone monitoring in sequential and relapsed pediatric B-cell acute lymphoblastic leukemia patients. Pediatr Blood Cancer. 2024;35:e31443.","journal-title":"Pediatr Blood Cancer"},{"key":"779_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000700","volume":"6","author":"S Meyers","year":"2022","unstructured":"Meyers S, Alberti-Servera L, Gielen O, Erard M, Swings T, De Bie J, et al. Monitoring of leukemia clones in B-cell acute lymphoblastic leukemia at diagnosis and during treatment by single-cell DNA Amplicon sequencing. Hemasphere. 2022;6: e700.","journal-title":"Hemasphere"},{"key":"779_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3265","volume":"42","author":"X Li","year":"2024","unstructured":"Li X, Lin S, Liao N, Mai H, Long X, Liu L, et al. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: a report from South China children\u2019s leukemia group. Hematol Oncol. 2024;42: e3265.","journal-title":"Hematol Oncol"},{"key":"779_CR51","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1182\/blood.2019002499","volume":"135","author":"MJ Barz","year":"2020","unstructured":"Barz MJ, Hof J, Groeneveld-Krentz S, Loh JW, Szymansky A, Astrahantseff K, et al. Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia. Blood. 2020;135:921\u201333.","journal-title":"Blood"},{"key":"779_CR52","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, Radtke I, Phillips LAA, Miller CB, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470\u201380.","journal-title":"N Engl J Med"},{"key":"779_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100677","volume":"44","author":"S Vairy","year":"2020","unstructured":"Vairy S, Tran TH. IKZF1 alterations in acute lymphoblastic leukemia: the good, the bad and the ugly. Blood Rev. 2020;44: 100677.","journal-title":"Blood Rev"},{"key":"779_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000782","volume":"6","author":"SK Gupta","year":"2022","unstructured":"Gupta SK, Singh M, Chandrashekar PH, Bakhshi S, Trehan A, Gupta R, et al. Clinical and prognostic impact of copy number alterations and associated risk profiles in a cohort of pediatric b-cell precursor acute lymphoblastic leukemia cases treated under ICiCLe Protocol. Hemasphere. 2022;6: e782.","journal-title":"Hemasphere"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00779-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-025-00779-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00779-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T20:02:43Z","timestamp":1746734563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-025-00779-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s40291-025-00779-5","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"16 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (S.S., V.T., A.B., M.U.S.S., P.K., S.R., M.J., C.S., P.S., N.M., S.N., P.R., A.J., G.P., A.K., P.M., and R.S.) declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"S.S. designed the study, obtained ethical approval and funding, analyzed the data, and wrote the\u00a0manuscript. V.T., A.S., P.K., and\u00a0M.J. performed NGS testing. S.S. and P.S. performed and analyzed FISH. S.S. performed the bioinformatic analysis of NGS data. C.S., P.S., N.M., S.N., M.U.S.S., A.J., G.P., P.M., and R.D. provided clinical and laboratory data, reviewed them, and approved the manuscript. All authors agree to the content of the manuscript and its interpretations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"This study was funded by an intramural research grant (IM\/135\/23-09-21-0114) from the Medical Education and Research Cell (MERC), Postgraduate Institute of Medical Education and Research (PGIMER), awarded to S.S.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}},{"value":"Data shall be shared upon reasonable request to the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"All procedures were conducted according to the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1975, as revised in 2008. The research was carried out according to the institutional ethics guidelines after obtaining the approval of the institute\u2019s ethics committee. The study did not involve any intervention based on the results of the study and did not involve any compensation for the participants. Written informed consent was obtained from all patients in this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The work does not involve the use of any large language models (LLMs).","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration on AI usage"}},{"value":"Not applicable.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}